
    
      This study consisted of a 1 week Screening Phase, a 4-week Randomization/Crossover Phase, a
      6-week Re-randomization Phase, followed by a 30 week Observational Phase.

      The total duration of study participation was up to 41 weeks with a total treatment duration
      of up to 40 weeks of Lantus exposure.
    
  